VB: Who is Romina?
RZ: Romina is a hyperactive person that never rests … I even wake up at night thinking about how I can help the world. This is my mission.
Overall, I am eager to learn how the material world functions and understand the laws of the spiritual world. I am very interested in the laws of the universe. My family calls me “Mouse” because I have to stick my nose everywhere and always understand how things work.
VB: Where is the source of your desire to innovate?
RZ: It is my inner drive, my inner inspiration. I see a lot of suffering around me and would like to alleviate this, for people and animals. My drive is also partially genetically preconditioned: my father innovated in the field of electronics, my grandfather in art…
VB: When did you first create something of your own?
RZ: When I was four. I took a red plastic dish, poured water into it and coloured it with a spice. I proudly walked around proclaiming it to be my new medicine for all illnesses. Then, I stole a syringe from my grandmother and stuck it into a tree. I was deeply disappointed at being unable to take a blood sample from it. I have always learned through curiosity.
VB: These are obviously the roots of your current desire to innovate. What is your focus today?
RZ: The new molecule we discovered causes necrosis of several types of cancer cells. I am currently looking for business partners who would help me develop the molecule on virtual models of animals, and later on human volunteers.
VB: Where do you perform your research?
RZ: The research work was performed at the Jožef Stefan Institute in Ljubljana (the research is the basis for an expert article and a later doctorate).
VB: What is the essence of this molecule?
RZ: It acts as an “eraser”. Micro tumours are created daily in our bodies. Most of them are successfully eliminated by the body, but some of them grow into larger tumours and finally become metastatic (spread all over the body). If a high enough level of these "eraser" molecules is achieved in the blood and tissue, they successfully eliminate tumours while the rest of them are identified by the immune system and excreted from the body.
VB: The molecule was discovered in January 2010. Now, it is time for testing. What are your expectations? What do you envision at the end of this process?
RZ: We first need to test the molecule's behaviour in a living organism. We need to prove that the molecule initiates gradual necrosis of a tumour in a living organism. Ultimately, I wish we will be able to develop a drug that can be applied intratumorally (injected with a special tool directly into a tumour), intravenously or in the form of a pill.
Romina Znoj is a student of Nanotechnology and Nanoscience at the Jožef Stefan International Postgraduate School in Ljubljana who is completing her doctorate studies. She is a graduate of Medical Microbiology (University of Ljubljana) and Egyptology (University of London). She acquired her knowledge in pharmacy in the ten years she has been working in various pharmaceutical companies. Her greatest desire is to relieve the world from its suffering. This led her to the invention of many different things, most important of which are the new molecule for curing cancer and the virtual model for testing new drugs. She has been a vegan for ten years and has been active in fencing in the last five. This year, she exchanged weapons for a violin, a piano and an Irish flute, and acquired diplomas in music as well.VB: How does your invention currently stand?
RZ: In the preclinical phase, and are ready now to enter the clinical phase. There are three more phases that will follow. If these phases are competed successfully, the drug will be approved. Today, this means a process of ten to fifteen years, while virtual testing would shorten it to approximately three years. I truly wish this new medicine will be kinder to all living beings. I wish it could be tested on virtual models, and therefore, we are looking for a partner who would be open to such an approach.
The motivation for virtual testing is also based on the fact that the molecule in its current state cannot be tested on animals. Their enzymes would decompose the molecule while human enzymes would not, according to our preliminary findings.
VB: Are virtual drug testing models already used in practice?
RZ: Some prototypes have been developed but I think they are not yet used in practice. Many people are working diligently in this direction. I have also developed a prototype of a drug testing computer model and patented it.
VB: Where did you acquire the knowledge for such a discovery?
RZ: I am a medical microbiologist and an Egyptologist by profession. I am also a polyglot – I fluently speak seven languages. Since my graduate studies, it has always been my desire to transfer ancient knowledge of medicine (and other areas) to modern times. To combine ancient knowledge and wisdom with modern scientific techniques whilst upgrading and transforming them for the benefit of all living beings but for humanity in particular. This is also the case with my latest innovation (V: the discovery of the new molecule for curing cancer). I drew from ancient knowledge (through archaeology) and added modern knowledge of medical biology. Thus we developed a plant extract in the laboratory which led to the discovery of the new molecule.
VB: What sort of a market potential does it have?
RZ: Enormous – the incidence of cancer is growing. It has reached the level of cardiovascular diseases.
VB: What else could the molecule affect?
RZ: It could affect the concept of formation of any disease. The molecule I have isolated is present in every plant. There are different molecules for different disease, but they all function on the same fundamental principle. I believe that my discovery holds the key to curing, and additionally, the prevention of all terminal diseases.
It is also interesting that if the molecule is ingested by vegans and vegetarians it will be most unlikely for them to become ill with any of the severe illnesses, even though they do not eat every existing plant. If a person regularly eats a lot of vegetables, they introduce high quantities of the molecule into their bodies. Since, as far as we know the human body does not contain the enzyme that could decompose the molecule, it is absorbed directly into the blood. In time, a certain concentration of this and other similar molecules is established in the blood and they protect the body in the short and the long-term.
Non-vegetarians are unable to establish this level of concentration naturally and thus they need this in supplement form. This would also include everyone who has already become ill, of course.
VB: This leads to the conclusion that lack of this molecule in the body (lack of fruit and vegetables in one’s diet) can lead to cancer. Does this mean that the belief that radiation, stress and emotional pressure are the causes of cancer is erroneous?
RZ: Based on my research, I believe that the fundamental cause is the lack of this and other natural molecules. This is the reason ancient cultures did not know cancer. They ate meat only on holidays, otherwise people were mainly vegetarians. If a person’s body maintains a high enough level of these molecules, they protect them from the consequences of stress and radiation.However, this excludes extreme cases.
Awards for the discovery of the new molecule for curing cancer:VB: Can you support this thinking with a good example?
- Eureka! Innovation Award 2009, the Golden Plaque, 3rd place in the country and a special scholarship for 2010 by the Ljubljana Rotary Club, called The View From Another Window
- 2. First prize at the Korea International Women's Invention Exposition (KIWIE) in Seoul, South Korea, May 2010
- Bronze Medal for innovation in 2009 by the Chamber of Commerce and Industry of Slovenia, May 2010
- Gold Medal by Active Slovenian Innovators Association – ASI, May 2010
- Bronze medal at the Nikola Tesla International Congress on Innovation in SE Europe, Belgrade, May 2010
For the invention of the plant extract that cures cancer she received a Slovenian patent in October 2008 and an international publication of the patent in 2009. At the end of 2009, she submitted a new Slovenian and international patent applications for the virtual model of the laboratory mouse for testing new drugs.
RZ: Yes, I am the perfect example: I had epilepsy, an inflammation of the trigeminal nerve, chronic pneumonia, chronic sinusitis, a stomach ulcer and a spinal defect. I cured them all with a strict vegan diet. Now I am healthy, a sportswoman. I am not an isolated case. I know many people who could tell you the same story. My research has confirmed that I am on the right path. Once, I accidently forgot to add the source of animal nutrients to the cancer cell culture medium in the laboratory. The next day I found out that the cancer cells did not multiply. I waited for a few days and found they had started dying the day after I started this. Further research with the plant extract confirmed this interesting discovery. Many discoveries are made, seemingly, by coincidence.
VB: How does the world of innovators accept your story and your discovery?
RZ: They find it unusual, but it was accepted very well. As far as science is concerned, it awaits testing on living organisms, or on virtual models of living organisms.
VB: Are you already planning new discoveries or is this the story of a lifetime?
RZ: Hmm. I am very open to everything and I follow my inner voice. I am convinced I will invent something else. My virtual laboratory mouse model was also created in the middle of the night. I woke up, wrote it down and later found that it worked exceptionally well.
VB: Thank you for the inspiration, for thinking outside the borders of the known, for your casualness and insight. I hope your invention is developed to a drug soon and for the “good of all living beings”.
Links: http://www.egipt-slo.net; http://www.ijs.si